0000950170-24-046417.txt : 20240422 0000950170-24-046417.hdr.sgml : 20240422 20240422160514 ACCESSION NUMBER: 0000950170-24-046417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240205 FILED AS OF DATE: 20240422 DATE AS OF CHANGE: 20240422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIINBERG ULF CENTRAL INDEX KEY: 0001187314 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 24861179 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 ownership.xml 4 X0508 4 2024-02-05 0001098972 AGENUS INC AGEN 0001187314 WIINBERG ULF C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 true false false false false Stock Option 12.6 2024-02-05 4 A false 5000 0.00 A 2034-02-05 Common Stock 5000 5000 D The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63. /s/Christine Klaskin, as Attorney-in-Fact for Ulf Wiinberg 2024-04-22